🙏Namaste!🙏
Tryambak is a postdoctoral researcher at the Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
His primary research focuses on unraveling the role of the Androgen Receptor in Breast cancer progression. This comprehensive study encompasses cell line investigations, in vivo, and clinical research involving patients undergoing surgical interventions. By integrating basic science with clinical applications, he is part of a multidisciplinary team that aims to uncover novel therapeutic targets in Triple-negative breast cancer, which is a more aggressive form of breast cancer. His research is now revolving around nuclear receptors and their cross-talk. This collaborative effort includes contributions from basic scientists, pathologists, surgeons, and oncologists specializing in medical, surgical, and laboratory disciplines.
His academic journey began with an integrated B.Sc. B.Ed. program at the Regional Institute of Education, Bhubaneswar. This program laid the foundation for both scientific knowledge and educational methodologies. Following this, he pursued an MSc. in Biotechnology from South Asian University (SAU), New Delhi. His master’s dissertation evaluated the efficacy of a maturation inhibitor against HIV-1 Subtype C, a strain prevalent in South Asia and Africa. This research not only honed his skills in molecular biology but also instilled a deep interest in translational research. During his time at SAU, he was actively involved in a wide range of extracurricular activities, participating in various university and inter-university events, which enriched his academic and personal development. Following this, Tryambak attended the prestigious All India Institute of Medical Sciences, New Delhi, for a PhD in Biochemistry. His passion for biomedical research led him to his current position as a postdoc at UT Southwestern Medical Center.
Beyond the lab, Tryambak is passionate about science communication and strives to make science accessible and engaging for all. As a blogger, he shares his thoughts and discoveries through various forms of writing, including micro-fiction, poetry, and contemplative essays. In 2020, he embarked on the #365DaysOfScience initiative, where he committed to sharing a science-related tweet every day for 365 consecutive days. This project allowed him to explore and communicate a wide array of scientific topics, from fundamental concepts to cutting-edge research. In 2021, he expanded his efforts with the #TWiS (This Week in Science) section on my blog, providing detailed discussions on recent scientific papers and developments. In 2022, he challenged himself further by reading and tweeting about a scientific paper daily, fostering continuous learning and engagement with the latest research.
Outside of his professional and academic pursuits, Tryambak enjoys exploring the intersections of science and art, reflecting on the broader implications of scientific discoveries, and engaging with the community and writing. His blog serves as a platform for sharing his journey, insights, and creative expressions. He takes immense pride in my roots and his mother tongue, Bhojpuri. He is committed to promoting science communication in vernacular languages, making scientific knowledge more accessible to non-English speaking communities. By bridging the gap between advanced scientific research and regional languages, he hopes to foster a greater appreciation and understanding of science among diverse audiences.
Tryambak invites you to explore his work, join the conversation, and connect with him as we navigate the fascinating world of science together. May the mitochondria be with you! 🧬🔬
HONORS AND AWARDS
AWARDS | ORGANIZATION | YEAR |
---|---|---|
Young Researcher Award | Society of Young Biomedical Scientists | December 2024 |
Reviewer for Cell Communication and Signaling, Discover Oncology, Frontiers in Oncology, and Indian Journal of Surgical Oncology Journals | Springer Nature and Frontiers | June 2023 onwards |
Travel grant of 3,000 EUR to attend the Global Bioimaging course in Japan | European Molecular Biology Laboratory (EMBL), Heidelberg | July 2023 |
Second prize in poster and third prize in the quiz competition | Oncovision 2022 | November 2022 |
Young Investigator Award | Korean Society of Medical Oncology, South Korea | September 2022 |
International travel grants | Government agencies (SERB, ICMR, AIIMS, CSIR, DBT) | March 2022 to December 2023 |
Qualified Junior Research Fellowship (CSIR-UGC-JRF) in Life Sciences (AIR: 78) | Council of Scientific and Industrial Research (CSIR) | June 2019 |
Qualified Lectureship (CSIR-NET) in Life Sciences (AIR: 34) | Council of Scientific and Industrial Research (CSIR) | June 2018 |
IELTS Academic overall band score 7.5 (L-8.5, R-8, W-6.5, S-7) | British Council | February 2018 |
Received Israel government scholarship to attend Weizmann Institute of Science | Israel government | February 2018 |
Graduate Aptitude Test in Engineering (GATE) Life Sciences | IIT Roorkee | March 2017 |
Merit-cum-Means scholarship | South Asian University | Aug 2014 – May 2016 |
NCERT merit scholarship | National Council of Educational Research and Training (NCERT) | Aug 2010 – May 2014 |
PROFESSIONAL MEMBERSHIPS
American Society of Clinical Oncology (ASCO) |
American Association for Cancer Research (AACR) |
European Society for Medical Oncology (ESMO) |
American Society for Clinical Pathology (ASCP) |
Society for Immunotherapy of Cancer (SITC) |
American Urological Association (AUA) |
National Postdoctoral Association of USA |